Study points to lower-dose nano vitamin D3 benefits in broilers

A new study published July 3, 2026, in BMC Veterinary Research suggests that nano-formulated vitamin D₃ could improve broiler growth and bone development more efficiently than conventional vitamin D₃, at least under the conditions tested. The researchers concluded that 2,500 IU/kg nano-VD₃ was the optimal level in their trial, outperforming 3,750 IU/kg conventional vitamin D₃ on average daily gain and multiple bone measures, while a higher nano dose underperformed. (link.springer.com)

That matters because skeletal problems remain a stubborn issue in broiler production. Vitamin D is central to calcium and phosphorus homeostasis, bone mineralization, and overall growth, and prior poultry research has already shown that different vitamin D forms and metabolites can affect performance, bone traits, gut integrity, and microbial balance. More recent studies have also tied vitamin D supplementation to shifts in cecal microbiota and intestinal immune function, which helps explain why nutrition teams are looking beyond simple deficiency prevention toward more targeted supplementation strategies. (pubmed.ncbi.nlm.nih.gov)

In the new paper, investigators at Northwest Minzu University in China studied 420 male Luhua broilers over 84 days. Birds were assigned to four diets: basal feed alone, 3,750 IU/kg conventional vitamin D₃, 2,500 IU/kg low-dose nano-VD₃, or 3,750 IU/kg high-dose nano-VD₃. According to the abstract, both conventional vitamin D₃ and low-dose nano-VD₃ improved growth and bone development versus control, but the low-dose nano treatment delivered the strongest results, including better fresh bone weight, fat-free dry weight, yield strength, elastic modulus, calcium content, ash content, and osteogenic gene expression in the femur and tibia. By contrast, the higher-dose nano group showed declines in average daily gain and bone indices. (link.springer.com)

The microbiome and metabolomics findings are a major part of the paper’s proposed mechanism. The low-dose nano-VD₃ group had higher relative abundance of bacteria including Ligilactobacillus, Muribaculaceae, and NK4A214_group, alongside higher levels of metabolites such as butyric acid, kynurenic acid, and glutathione. At the same time, the group had lower abundance of Desulfovibrio and Campylobacter jejuni, plus lower levels of metabolites associated with oxidative stress and inflammation. The authors reported correlations between those microbial and metabolic shifts and improved growth and bone traits, suggesting the bone effects may be mediated partly through gut remodeling rather than mineral metabolism alone. That interpretation is consistent with earlier broiler studies linking vitamin D-related interventions to gut barrier function, cytokine signaling, and microbiota composition. (link.springer.com)

Independent expert reaction specifically addressing this paper was not readily available in initial reporting, but the broader literature points in the same direction: vitamin D source and bioavailability can matter as much as nominal inclusion rate. A 2025 Frontiers in Veterinary Science study in broilers found that supplemental vitamin D₃ improved average daily gain over the full study period and altered cecal microbiota, while the authors noted no food safety concerns at 3,750 IU/kg in that setting. Other recent work has suggested that 25-hydroxyvitamin D₃ and related strategies can support skeletal development and microbial balance, though results vary by formulation, dose, bird type, and study design. (frontiersin.org)

Why it matters: For veterinarians and poultry health teams, the study is less about a single additive and more about a familiar challenge: how to improve leg health and growth without simply increasing nutrient inclusion. If nano-VD₃ reliably delivers better bioavailability at lower doses, it could eventually influence feed formulation, lameness prevention strategies, welfare outcomes, and production economics. But there are important caveats. The paper is currently presented as an unedited early-access manuscript, it focused on one medium-growth Chinese breed, and the apparent dose-response curve raises practical questions about safety margins, consistency, and how nano-formulations behave under commercial feed manufacturing and field conditions. (link.springer.com)

There’s also a regulatory and implementation angle. Nano-formulated feed additives can face a different scrutiny threshold than conventional vitamins, especially if manufacturers seek broader commercial adoption across markets. Before this becomes a practical recommendation, nutritionists and veterinary advisers will likely want replication in standard commercial broiler lines, head-to-head economic modeling, residue and safety data, and validation under stressors such as rapid growth, heat, or suboptimal mineral balance. (link.springer.com)

What to watch: The next signals will be whether the authors publish the final edited version with fuller methods and statistics, whether outside groups replicate the 2,500 IU/kg nano-VD₃ finding, and whether feed companies begin pilot work to test nano-vitamin D strategies in commercial broiler programs. (link.springer.com)